These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 27053685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers.
    Bagher AM, Laprairie RB, Toguri JT, Kelly MEM, Denovan-Wright EM.
    Eur J Pharmacol; 2017 Oct 15; 813():66-83. PubMed ID: 28734930
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB, Bagher AM, Kelly ME, Dupré DJ, Denovan-Wright EM.
    J Biol Chem; 2014 Sep 05; 289(36):24845-62. PubMed ID: 25037227
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons.
    Bertran-Gonzalez J, Håkansson K, Borgkvist A, Irinopoulou T, Brami-Cherrier K, Usiello A, Greengard P, Hervé D, Girault JA, Valjent E, Fisone G.
    Neuropsychopharmacology; 2009 Jun 05; 34(7):1710-20. PubMed ID: 19158668
    [Abstract] [Full Text] [Related]

  • 8. Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments.
    Bagher AM, Young AP, Laprairie RB, Toguri JT, Kelly MEM, Denovan-Wright EM.
    J Neurosci Res; 2020 Dec 05; 98(12):2496-2509. PubMed ID: 32881145
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum.
    Martínez-Pinilla E, Rodríguez-Pérez AI, Navarro G, Aguinaga D, Moreno E, Lanciego JL, Labandeira-García JL, Franco R.
    Biochem Pharmacol; 2015 Jul 15; 96(2):131-42. PubMed ID: 25986885
    [Abstract] [Full Text] [Related]

  • 12. Cannabinoid 2 receptors regulate dopamine 2 receptor expression by a beta-arrestin 2 and GRK5-dependent mechanism in neuronal cells.
    Franklin JM, Broseguini de Souza RK, Carrasco GA.
    Neurosci Lett; 2021 May 14; 753():135883. PubMed ID: 33838258
    [Abstract] [Full Text] [Related]

  • 13. Endocytosis following dopamine D2 receptor activation is critical for neuronal activity and dendritic spine formation via Rabex-5/PDGFRβ signaling in striatopallidal medium spiny neurons.
    Shioda N, Yabuki Y, Wang Y, Uchigashima M, Hikida T, Sasaoka T, Mori H, Watanabe M, Sasahara M, Fukunaga K.
    Mol Psychiatry; 2017 Aug 14; 22(8):1205-1222. PubMed ID: 27922607
    [Abstract] [Full Text] [Related]

  • 14. GIV/Girdin activates Gαi and inhibits Gαs via the same motif.
    Gupta V, Bhandari D, Leyme A, Aznar N, Midde KK, Lo IC, Ear J, Niesman I, López-Sánchez I, Blanco-Canosa JB, von Zastrow M, Garcia-Marcos M, Farquhar MG, Ghosh P.
    Proc Natl Acad Sci U S A; 2016 Sep 27; 113(39):E5721-30. PubMed ID: 27621449
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S.
    J Neurochem; 2004 Sep 27; 90(5):1117-31. PubMed ID: 15312167
    [Abstract] [Full Text] [Related]

  • 16. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
    Laprairie RB, Kelly ME, Denovan-Wright EM.
    Neuropharmacology; 2013 Sep 27; 72():47-57. PubMed ID: 23602984
    [Abstract] [Full Text] [Related]

  • 17. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
    Dang DK, Shin EJ, Mai AT, Jang CG, Nah SY, Jeong JH, Ledent C, Yamamoto T, Nabeshima T, Onaivi ES, Kim HC.
    Free Radic Biol Med; 2017 Jul 27; 108():204-224. PubMed ID: 28363605
    [Abstract] [Full Text] [Related]

  • 18. G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors.
    Choi EY, Jeong D, Park KW, Baik JH.
    Biochem Biophys Res Commun; 1999 Mar 05; 256(1):33-40. PubMed ID: 10066418
    [Abstract] [Full Text] [Related]

  • 19. Opposite regulation by L-DOPA receptor GPR143 of the long and short forms of the dopamine D2 receptors.
    Tajika R, Masukawa D, Arai M, Nawa H, Goshima Y.
    J Pharmacol Sci; 2024 Oct 05; 156(2):77-81. PubMed ID: 39179337
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.